ASTMExecution MethodologyStandard
ASTM E2500

Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment

The consensus standard that established the risk- and science-based approach to specifying, designing, and verifying manufacturing systems and equipment. It replaces prescriptive, document-driven qualification with verification focused on the critical aspects that affect product quality and patient safety, leveraging Good Engineering Practice and subject-matter-expert judgement.

LAST REVISED
January 2020
PRODUCT AREAS
SterileSolid DoseBiotechApi
SCOPE & APPLICABILITY

Manufacturing systems and equipment across pharmaceutical and biopharmaceutical operations — process, utility, and automation systems whose performance can affect product quality.

KEY REQUIREMENTS
  • 01Requirements based on product and process understanding, not generic checklists
  • 02Risk-based identification of Critical Aspects requiring verification
  • 03Verification (in place of prescriptive qualification) with documented SME involvement
  • 04Leverage of Good Engineering Practice, supplier, and commissioning documentation
  • 05Formal acceptance and release tied to the controlled critical aspects
IMPLEMENTATION TIPS
Use ICH Q9 quality risk management to scope verification — do not qualify everything to the same depth
Involve subject-matter experts and the quality unit early so their judgement is documented, not retrofitted
Map Critical Aspects back to CQAs/CPPs so the verification rationale survives inspection
REVISION NOTES

First published 2007 and reapproved with editorial updates (E2500-13, reapproved 2020). It is the technical basis for the ISPE Baseline Guide Vol. 5 (2019) 2nd edition C&Q approach.

ASTM E2500: frequently asked questions

Quick answers to common questions about ASTM E2500.

What is ASTM E2500?

ASTM E2500 — Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment — is a standard issued by the ASTM International. The consensus standard that established the risk- and science-based approach to specifying, designing, and verifying manufacturing systems and equipment. It replaces prescriptive, document-driven qualification with verification focused on the critical aspects that affect product quality and patient safety, leveraging Good Engineering Practice and subject-matter-expert judgement.

Who does ASTM E2500 apply to?

Manufacturing systems and equipment across pharmaceutical and biopharmaceutical operations — process, utility, and automation systems whose performance can affect product quality.

What are the key requirements of ASTM E2500?

ASTM E2500 requires, among other things: Requirements based on product and process understanding, not generic checklists; Risk-based identification of Critical Aspects requiring verification; Verification (in place of prescriptive qualification) with documented SME involvement; Leverage of Good Engineering Practice, supplier, and commissioning documentation.

When was ASTM E2500 last updated?

The current version of ASTM E2500 dates from January 2020. First published 2007 and reapproved with editorial updates (E2500-13, reapproved 2020). It is the technical basis for the ISPE Baseline Guide Vol. 5 (2019) 2nd edition C&Q approach.

RELATED STANDARDS
RELATED FDA RECALLS
where Validation & Qualification control fails
See all Validation & Qualification recalls →

Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

THIS STANDARD IN PRACTICE

Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.

Weekly Briefing

Track the standards that move

When ASTM E2500 — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.

Read a past issue →